Zymeworks Inc. (ZYME)
NASDAQ: ZYME
· Real-Time Price · USD
12.08
0.44 (3.78%)
At close: Jun 03, 2025, 3:59 PM
12.08
0.00%
After-hours: Jun 03, 2025, 06:02 PM EDT
Zymeworks Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|
| Milestone Revenue Revenue | 25M | 52.62M | 8.2M | 5.68M | 7.95M | 4.01M |
| Milestone Revenue Revenue Growth | -52.49% | +541.62% | +44.38% | -28.56% | +98.08% | n/a |
| Research Support Payments And Other Service Revenue | 2.83M | n/a | n/a | n/a | n/a | n/a |
| Research Support Payments And Other Service Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a |
| Royalty Revenue | 100K | n/a | n/a | n/a | n/a | n/a |
| Royalty Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 17M | 16.2M | 13.9M | 13.15M | 15.79M | 14.78M | 16.97M | 21.71M | 16.95M | 30.13M | 15.89M | 15.24M | 12.09M | 5.85M | 15.47M | 19.95M | 1.3M | 13.96M | 22.81M | 13.49M | 7.62M | 30.24M | 12.17M | 12.76M | 9M | 6.3M | 7.45M | 8.65M | 7.07M | 4.71M | 5.29M | 2.29M | 6.26M | 5.12M | 2.7M | 2.66M | 2.08M | 1.37M |
| Selling, General, and Administrative Revenue Growth | +4.94% | +16.55% | +5.70% | -16.72% | +6.86% | -12.91% | -21.84% | +28.09% | -43.76% | +89.60% | +4.26% | +26.06% | +106.56% | -62.15% | -22.46% | +1438.97% | -90.72% | -38.77% | +69.05% | +76.98% | -74.79% | +148.42% | -4.61% | +41.74% | +43.00% | -15.46% | -13.89% | +22.39% | +49.86% | -10.89% | +131.55% | -63.49% | +22.32% | +89.80% | +1.51% | +27.39% | +52.08% | n/a |
| Research and Development Revenue | 35.74M | 37.06M | 36.35M | 29.16M | 32.04M | 25.52M | 16.51M | 39.41M | 45.91M | 52.97M | 37.1M | 56.02M | 62.51M | 54.87M | 49.89M | 50.71M | 44.28M | 39.26M | 53.53M | 39.22M | 36.53M | 45.39M | 7.86B | 23.79M | 17.48M | 14.09M | 14.14M | 15.37M | 13.09M | 12.88M | 11.53M | 8.29M | 9.06M | 8.92M | 9.76M | 10.22M | 7.92M | 8.24M |
| Research and Development Revenue Growth | -3.57% | +1.95% | +24.65% | -8.99% | +25.54% | +54.63% | -58.12% | -14.17% | -13.32% | +42.78% | -33.78% | -10.38% | +13.93% | +9.97% | -1.61% | +14.52% | +12.79% | -26.66% | +36.50% | +7.37% | -19.53% | -99.42% | +32946.04% | +36.11% | +24.03% | -0.37% | -7.98% | +17.45% | +1.62% | +11.73% | +39.04% | -8.49% | +1.57% | -8.62% | -4.54% | +29.14% | -3.90% | n/a |